These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10444271)

  • 21. Elevated interleukin-18 levels in the urine of nephrotic patients.
    Matsumoto K; Kanmatsuse K
    Nephron; 2001 Aug; 88(4):334-9. PubMed ID: 11474228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular permeability increasing factor (VPF) in IgA nephropathy.
    Bakker WW; Beukhof JR; van Luijk WH; van der Hem GK
    Clin Nephrol; 1982 Oct; 18(4):165-7. PubMed ID: 7140031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy.
    Mao J; Zhang Y; Du L; Dai Y; Yang C; Liang L
    Pediatr Nephrol; 2006 Nov; 21(11):1666-75. PubMed ID: 16941146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-17 stimulates the release of pro-inflammatory cytokines by blood monocytes in patients with IgA nephropathy.
    Matsumoto K; Kanmatsuse K
    Scand J Urol Nephrol; 2003; 37(2):164-71. PubMed ID: 12745727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-8 release from cultured peripheral blood monocytes of patients with glomerulonephritis.
    Matsumoto K
    Clin Exp Immunol; 1995 Jan; 99(1):106-11. PubMed ID: 7813101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
    Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FK 506 for vascular permeability factor production in minimal change nephrotic syndrome.
    Maruyama K; Tomizawa S; Seki Y; Arai H; Ogawa T; Kuroume T
    Nephron; 1994; 66(4):486-7. PubMed ID: 7517020
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased release of tumor necrosis factor-alpha by monocytes from patients with glomerulonephritis.
    Matsumoto K
    Clin Nephrol; 1993 Sep; 40(3):148-54. PubMed ID: 8403569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome.
    Cho BS; Yoon SR; Jang JY; Pyun KH; Lee CE
    Pediatr Nephrol; 1999 Apr; 13(3):199-204. PubMed ID: 10353405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell subsets in glomerulonephritis.
    Lin CY; Yang YM; Fu YK
    Int J Pediatr Nephrol; 1986; 7(2):63-8. PubMed ID: 3487514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two-color analysis of lymphocyte subpopulations in membranous nephropathy and minimal change nephrotic syndrome].
    Ozaki T
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):797-806. PubMed ID: 2593316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in DNA methylation in naïve T helper cells regulate the pathophysiological state in minimal-change nephrotic syndrome.
    Kobayashi Y; Aizawa A; Takizawa T; Igarashi K; Hatada I; Arakawa H
    BMC Res Notes; 2017 Sep; 10(1):480. PubMed ID: 28915836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling of peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome by cDNA microarrays.
    Komatsuda A; Wakui H; Iwamoto K; Harada M; Okumoto Y; Sawada K
    Am J Nephrol; 2008; 28(4):539-47. PubMed ID: 18219197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinico-pathological evaluation of mesangial IgA deposition of minimal change with nephrotic syndrome].
    Hamaguchi K; Tuchida H; Suzuki S; Miura Y; Nakazawa R; Suhara Y; Mimura N
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1071-7. PubMed ID: 2287099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased urinary excretion of interleukin-17 in nephrotic patients.
    Matsumoto K; Kanmatsuse K
    Nephron; 2002 Jun; 91(2):243-9. PubMed ID: 12053060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults.
    Oniszczuk J; Beldi-Ferchiou A; Audureau E; Azzaoui I; Molinier-Frenkel V; Frontera V; Karras A; Moktefi A; Pillebout E; Zaidan M; El Karoui K; Delfau-Larue MH; Hénique C; Ollero M; Sahali D; Mahévas M; Audard V
    Nephrol Dial Transplant; 2021 Mar; 36(4):609-617. PubMed ID: 33241414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy.
    De Fijter JW; Daha MR; Schroeijers WE; van Es LA; Van Kooten C
    Clin Exp Immunol; 1998 Feb; 111(2):429-34. PubMed ID: 9486415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy.
    Matsumoto K; Kanmatsuse K
    Nephron; 2002 Oct; 92(2):309-15. PubMed ID: 12218308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
    Pruna A; Barka A; Nochy D; Hauet T; Boulanger H; Landais P
    Nephrologie; 1997; 18(3):95-101. PubMed ID: 9297136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Cho MH; Hong EH; Lee TH; Ko CW
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.